Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2026-06-08 16:15:06 ET · period of report 2026-06-04 · accession 0001280044-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-08 16:15 | 2026-06-05 | ACRS | GOWEN MAXINE | Dir | M - OptEx | — | +11.6K | 33.3K | +53% | — |
| DM | 2026-06-08 16:15 | 2026-06-04 | ACRS | GOWEN MAXINE | Dir | A - Grant | $0.00 | +53.3K | 11.0K | New | $0 |
| D | 2026-06-08 16:15 | 2026-06-05 | ACRS | GOWEN MAXINE | Dir | M - OptEx | $0.00 | -11.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-05 | M | A | 11,580 | — | 33,334 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-04 | A | A | 42,350 | $0.00 | 42,350 | D | $4.71 · — to 2036-06-03 | 42,350 Common Stock | (F2) The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 4, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan, or the Plan) through each such vesting date. (F3) This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy. |
| 3 | Derivative | Restricted Stock Units | 2026-06-04 | A | A | 10,987 | $0.00 | 10,987 | D | — · — to — | 10,987 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F4) The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date. (F4) The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date. (F3) This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy. |
| 4 | Derivative | Restricted Stock Units | 2026-06-05 | M | D | 11,580 | $0.00 | 0 | D | — · — to — | 11,580 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F5) The shares underlying these restricted stock units vested on June 5, 2026. (F5) The shares underlying these restricted stock units vested on June 5, 2026. |